Beneficial Effects of <i>Limosilactobacillus fermentum</i> in the DCA Experimental Model of Irritable Bowel Syndrome in Rats
<i>Limosilactobacillus fermentum CECT5716</i>, a probiotic strain isolated from human milk, has reported beneficial effects on different gastrointestinal disorders. Moreover, it has shown its ability to restore altered immune responses, in association with microbiome modulation in differ...
Main Authors: | María Jesús Rodríguez-Sojo, Jorge Garcia-Garcia, Antonio Jesús Ruiz-Malagón, Patricia Diez-Echave, Laura Hidalgo-García, José Alberto Molina-Tijeras, Elena González-Lozano, Laura López-Escanez, María Elena Rodríguez-Cabezas, Maria José Rodríguez-Sánchez, Alba Rodríguez-Nogales, Cristina Mediavilla, Julio Galvez |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-12-01
|
Series: | Nutrients |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6643/15/1/24 |
Similar Items
-
<i>Limosilactobacillus fermentum</i> CECT5716: Mechanisms and Therapeutic Insights
by: María Jesús Rodríguez-Sojo, et al.
Published: (2021-03-01) -
<i>Limosilactobacillus fermentum</i> CECT5716: Clinical Potential of a Probiotic Strain Isolated from Human Milk
by: Metehan Ozen, et al.
Published: (2023-05-01) -
Lactobacillus fermentum CECT5716 – prevention and treatment of lactational mastitis
by: A. О. Karapetyan
Published: (2019-10-01) -
Lactobacillus fermentum CECT5716 Alleviates the Inflammatory Response in Asthma by Regulating TLR2/TLR4 Expression
by: Weifang Wang, et al.
Published: (2022-07-01) -
Lactobacillus fermentum CECT 5716 and a reduction of the Staphylococcus load in breast milk which reduces the risk of infectious mastitis: evaluation of a health claim pursuant to Article 14 of Regulation (EC) No 1924/2006
by: EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA), et al.
Published: (2017-07-01)